BIO-key International, Inc.
BKYI
$0.8548
$0.03484.24%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -18.02% | -10.64% | -5.15% | -3.86% | 6.74% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -18.02% | -10.64% | -5.15% | -3.86% | 6.74% |
| Cost of Revenue | -76.06% | -79.61% | -45.29% | -8.03% | 54.94% |
| Gross Profit | 107.65% | 294.06% | 88.84% | 2.23% | -36.22% |
| SG&A Expenses | -14.02% | -10.50% | -15.62% | -20.30% | -17.04% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -31.51% | -34.02% | -24.50% | -18.00% | -4.54% |
| Operating Income | 45.32% | 54.56% | 40.65% | 28.67% | 13.85% |
| Income Before Tax | 39.15% | 50.05% | 56.57% | 50.19% | 40.74% |
| Income Tax Expenses | 82.84% | 82.84% | -326.14% | -325.94% | -556.86% |
| Earnings from Continuing Operations | 38.36% | 49.53% | 59.12% | 52.69% | 41.71% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 38.36% | 49.53% | 59.12% | 52.69% | 41.71% |
| EBIT | 45.32% | 54.56% | 40.65% | 28.67% | 13.85% |
| EBITDA | 47.50% | 56.97% | 43.69% | 30.36% | 15.25% |
| EPS Basic | 84.22% | 86.38% | 76.52% | 68.28% | 53.76% |
| Normalized Basic EPS | 85.05% | 87.19% | 66.79% | 55.54% | 38.30% |
| EPS Diluted | 84.22% | 86.38% | 76.52% | 68.28% | 53.76% |
| Normalized Diluted EPS | 85.05% | 87.19% | 66.79% | 55.54% | 38.30% |
| Average Basic Shares Outstanding | 244.71% | 283.20% | 175.92% | 124.93% | 77.90% |
| Average Diluted Shares Outstanding | 244.71% | 283.20% | 175.92% | 124.93% | 77.90% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |